REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinew Pharma Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sinew Pharma Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Sinew Pharma Inc. specializes in medical pharmacy. The company specializes in fatty liver therapy. Sinew Pharma Inc. was established in 2014 and located in Taipei City.

Headquarters
C516, Building C, No.99, Lane 130, Sec.1, Academia Rd
Taipei City; Taipei City;

Contact Details: Purchase the Sinew Pharma Inc. report to view the information.

Website: http://www.sinewpharma.com

Basic Information
Total Employees:
Purchase the Sinew Pharma Inc. report to view the information.
Outstanding Shares:
Purchase the Sinew Pharma Inc. report to view the information.
Financial Auditors:
Purchase the Sinew Pharma Inc. report to view the information.
Incorporation Date:
June 18, 2014
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
10.23%
Purchase this report to view the information.
5.12%
Purchase this report to view the information.
2.28%
Purchase this report to view the information.
0.68%
Purchase this report to view the information.
0.49%
Subsidiaries
定期存款
Company Performance
Financial values in the chart are available after Sinew Pharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-12.22%
EBITDA
-3.61%
Net Profit (Loss) for the Period
-7.28%
Total assets
-6.61%
Total equity
-7.12%
Return on Equity (ROE)
-0.63%
Quick Ratio
-25.9%
Cash Ratio
-11.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?